GlobeImmune Inc. (NasdaqCM:GBIM) retained financial advisor Cantor Fitzgerald, L.P. to assist in "evaluating strategic alternatives intended to maximize shareholder value."
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% |
|
-.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 5 | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- GBIM Stock
- News GlobeImmune, Inc.
- GlobeImmune Explores Strategic Alternatives